- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/365 - Lactones
Patent holdings for IPC class A61K 31/365
Total number of patents in this class: 1999
10-year publication summary
166
|
175
|
155
|
176
|
146
|
166
|
180
|
136
|
136
|
40
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19681 |
32 |
The Board of Trustees of the Leland Stanford Junior University | 6296 |
24 |
Chengdu Baiyu Pharmaceutical Co., Ltd. | 72 |
21 |
Eisai R&D Management Co., Ltd. | 1234 |
14 |
Accendatech | 16 |
12 |
The Trustees of the University of Pennsylvania | 4282 |
11 |
Aphios Corporation | 43 |
11 |
Nankai University | 224 |
11 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 806 |
10 |
Sloan-Kettering Institute for Cancer Research | 492 |
10 |
Empros Pharma AB | 13 |
10 |
Synaptogenix, Inc. | 22 |
10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
9 |
Theravance Biopharma R&D IP, LLC | 460 |
9 |
Boehringer Ingelheim Animal Health USA Inc. | 420 |
9 |
Novartis AG | 11042 |
8 |
Wisconsin Alumni Research Foundation | 3858 |
8 |
The Johns Hopkins University | 5575 |
8 |
Northwestern University | 3314 |
8 |
Everfront Biotech Inc. | 12 |
8 |
Other owners | 1756 |